Advanced Biomed Announces 1-For-20 Share Consolidation, Effective February 20
Benzinga Newsdesk 8 months ago
NewsStock Split
Advanced Biomed Inc. (NASDAQ:ADVB) (the "Company" or "Advanced Biomed"), a biotechnology company focused on developing and commercializing innovative biomedical products for precision medicine and advanced diagnostics,
Advanced Biomed Inc. (NASDAQ:ADVB) (the "Company" or "Advanced Biomed"), a biotechnology company focused on developing and commercializing innovative biomedical products for precision medicine and advanced diagnostics, today announced a reverse stock split of the Company's issued and outstanding common stock at a ratio of 1 for 20 shares (the "Reverse Split"), which will take effect at the open of The Nasdaq Stock Market ("Nasdaq") on February 20, 2026.